Latest news
TNXP: Tonmya's launch fueled major Q2 revenue growth and pipeline progress, with cash runway into 2027 - TradingViewTradingView · Mon, 10 Aug 2026 14:19:14 GMTTNXP: TONMYA sales nearly tripled in Q2 2026, driving revenue growth and supporting robust pipeline progress - TradingViewTradingView · Mon, 10 Aug 2026 13:32:08 GMTTNXP: Q2 2026 net revenue reached $13.5M, driven by TONMYA's 197% QoQ sales growth - TradingViewTradingView · Mon, 10 Aug 2026 12:32:17 GMTTonix Pharmaceuticals Holding Corp. 2Q 2026: Revenue $13.54M, EPS ($2.44) — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 12:11:01 GMTTonix Pharmaceuticals posts $13.5M Q2 product revenue, $40.6M net loss - TradingViewTradingView · Mon, 10 Aug 2026 11:23:01 GMTTNXP: Q2 2026 revenue soared 575% year-over-year, driven by TONMYA sales and expanded coverage - TradingViewTradingView · Mon, 10 Aug 2026 11:08:44 GMTTNXP Q2'26 Earnings: EPS estimate is (2.64) USD - TradingViewTradingView · Fri, 07 Aug 2026 11:00:24 GMTTonix Pharmaceuticals Announces FDA Alignment on 3,300‑Participant Adaptive Phase 2 Lyme Study; TNX-4800 Dosing, 2027 Site Delivery - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMT